Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.71 USD | -4.67% | -10.64% | +13.07% |
15/05 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
09/05 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.07% | 699M | |
+14.84% | 121B | |
+18.31% | 112B | |
+2.94% | 22.72B | |
-18.26% | 20.82B | |
-18.47% | 16.66B | |
-42.36% | 16.36B | |
-14.23% | 16.19B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Wave Life Sciences : Mizuho Adjusts Price Target on WAVE Life Sciences to $21 From $19, Maintains Buy Rating